Cargando…
Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model
Currently, there is no registered treatment for infections with emerging zoonotic coronaviruses like SARS- and MERS-coronavirus. We here report that in cultured cells low-micromolar concentrations of alisporivir, a non-immunosuppressive cyclosporin A-analog, inhibit the replication of four different...
Autores principales: | de Wilde, Adriaan H., Falzarano, Darryl, Zevenhoven-Dobbe, Jessika C., Beugeling, Corrine, Fett, Craig, Martellaro, Cynthia, Posthuma, Clara C., Feldmann, Heinz, Perlman, Stanley, Snijder, Eric J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114565/ https://www.ncbi.nlm.nih.gov/pubmed/27840112 http://dx.doi.org/10.1016/j.virusres.2016.11.011 |
Ejemplares similares
-
Coronaviruses and arteriviruses display striking differences in their cyclophilin A-dependence during replication in cell culture
por: de Wilde, Adriaan H., et al.
Publicado: (2018) -
The Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2
por: Ogando, Natacha S., et al.
Publicado: (2020) -
SARS and MERS: recent insights into emerging coronaviruses
por: de Wit, Emmie, et al.
Publicado: (2016) -
SARS-Coronavirus Replication Is Supported by a Reticulovesicular Network of Modified Endoplasmic Reticulum
por: Knoops, Kèvin, et al.
Publicado: (2008) -
Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin
por: Falzarano, Darryl, et al.
Publicado: (2013)